Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Teixidó · SciRah

Researcher profile · Semantic Scholar

C. Teixidó

Share profile

C. Teixidó — researcher profile on SciRah

h-index: 29
Works: 136
Citations: 3,269

Most-cited papers

AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas
Moshe Elkabets, E. Pazarentzos, D. Juric, Q. Sheng +22 more
2015Cancer Cell293 citations Open access
Semantic Scholar
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients
N. Karachaliou, M. González-Cao, G. Crespo, A. Drozdowskyj +14 more
2018Therapeutic Advances in Medical Oncology254 citations Open access
Semantic Scholar
Molecular Markers and Targets in Melanoma
C. Teixidó, P. Castillo, C. Martinez-Vila, A. Arance +1 more
2021Cells203 citations Open access
Semantic Scholar
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.
Michäel Duruisseaux, A. Martínez-Cardús, M. Calleja-Cervantes, S. Moran +44 more
2018The Lancet Respiratory Medicine188 citations Open access
Semantic Scholar
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC
I. Chaib, N. Karachaliou, S. Pilotto, J. Codony-Servat +37 more
2017Journal of the National Cancer Institute188 citations Open access
Semantic Scholar
PD-L1 expression testing in non-small cell lung cancer
C. Teixidó, N. Vilariño, R. Reyes, N. Reguart
2018Therapeutic Advances in Medical Oncology154 citations Open access
Semantic Scholar
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
Kirstine Jacobsen, J. Bertran-Alamillo, M. Molina, C. Teixidó +15 more
2017Nature Communications149 citations Open access
Semantic Scholar
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy
J. Bertran-Alamillo, V. Cattan, M. Schoumacher, J. Codony-Servat +14 more
2019Nature Communications115 citations Open access
Semantic Scholar
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
L. Paré, T. Pascual, E. Seguí, C. Teixidó +29 more
2018Annals of Oncology90 citations Open access
Semantic Scholar
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.
N. Reguart, C. Teixidó, A. Giménez-Capitán, L. Paré +16 more
2017Clinical Chemistry68 citations
Semantic Scholar
Liquid Biopsy in Non-Small Cell Lung Cancer
M. Molina-Vila, C. Mayo-de-las-Casas, A. Giménez-Capitán, N. Jordana-Ariza +18 more
2016Frontiers in Medicine66 citations Open access
Semantic Scholar
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Non-Small Cell Lung Carcinoma Patients: the ROSING Study.
E. Conde, S. Hernandez, R. Martínez, B. Angulo +48 more
2019Journal of Thoracic Oncology47 citations Open access
Semantic Scholar
Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma
P. Duch, N. Díaz-Valdivia, R. Ikemori, M. Gabasa +13 more
2022Matrix Biology41 citations Open access
Semantic Scholar
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases
L. De Mattos-Arruda, C. Ng, S. Piscuoglio, M. González-Cao +20 more
2018OncoTarget40 citations Open access
Semantic Scholar
EBUS-TBNA Cytological Samples for Comprehensive Molecular Testing in Non–Small Cell Lung Cancer
R. Martín-DeLeon, C. Teixidó, C. Lucena, D. Martínez +13 more
2021Cancers38 citations Open access
Semantic Scholar
MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer
Yang Yang, Nandie Wu, Jie Shen, C. Teixidó +9 more
2016Gastric Cancer35 citations Open access
Semantic Scholar
Assays for predicting and monitoring responses to lung cancer immunotherapy
C. Teixidó, N. Karachaliou, M. González-Cao, Daniela Morales-Espinosa +1 more
2015Cancer Biology and Medicine35 citations
Semantic Scholar
MA03.08 Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer
R. Reyes, R. López-Castro, É. Auclin, T. Garcia +14 more
2021Journal of Thoracic Oncology32 citations Open access
Semantic Scholar
Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC
R. Martı́nez, G. Tapia, S. de Muga, A. Hernández +9 more
2019Oncoimmunology32 citations Open access
Semantic Scholar
Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death‐ligand 1 (PD‐L1) axis in post‐transplant lymphoproliferative disorders: association with Epstein–Barr virus, PD‐L1 copy number alterations, and outcome
L. Veloza, C. Teixidó, Natàlia Castrejón, F. Climent +14 more
2019Histopathology29 citations
Semantic Scholar
Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints
B. González-Farré, J. Ramis-Zaldivar, Natalia Castrejón de Anta, A. Rivas-Delgado +16 more
2022American Journal of Surgical Pathology26 citations Open access
Semantic Scholar
KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients.
Mónica Garzón, S. Villatoro, C. Teixidó, C. Mayo +5 more
2016Translational Lung Cancer Research22 citations Open access
Semantic Scholar
P53 in Penile Squamous Cell Carcinoma: A Pattern-Based Immunohistochemical Framework with Molecular Correlation
I. Trias, A. Saco, L. Marimón, Ricardo López del Campo +17 more
2023Cancers21 citations Open access
Semantic Scholar
Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis.
T. Pascual, B. González-Farré, C. Teixidó, L. Oleaga +11 more
2019JCO Precision Oncology21 citations Open access
Semantic Scholar
Anaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer
N. Karachaliou, M. Santarpia, María González Cao, C. Teixidó +5 more
2017Expert Opinion on Investigational Drugs21 citations
Semantic Scholar
Clinical Benefit From BRAF/MEK Inhibition in a Double Non-V600E BRAF Mutant Lung Adenocarcinoma: A Case Report.
R. Reyes, C. Mayo-de-las-Casas, C. Teixidó, C. Cabrera +6 more
2019Clinical Lung Cancer20 citations
Semantic Scholar
Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer
C. Aguado, C. Teixidó, R. Roman, R. Reyes +28 more
2020Molecular Oncology19 citations Open access
Semantic Scholar
RNA Analysis as a Tool to Determine Clinically Relevant Gene Fusions and Splice Variants.
C. Teixidó, A. Giménez-Capitán, M. Molina-Vila, V. Peg +4 more
2018Archives of Pathology & Laboratory Medicine19 citations Open access
Semantic Scholar
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform.
A. Giménez-Capitán, J. Bracht, J. Garcia, N. Jordana-Ariza +16 more
2021Clinical Chemistry17 citations Open access
Semantic Scholar
In Search of the Long-Desired ‘Copernican Therapeutic Revolution’ in Small-Cell Lung Cancer
N. Reguart, E. Marin, J. Remon, R. Reyes +1 more
2020Drugs17 citations
Semantic Scholar
Fatal gastrointestinal toxicity with ipilimumab after BRAF/MEK inhibitor combination in a melanoma patient achieving pathological complete response
M. González-Cao, A. Boada, C. Teixidó, M. Férnandez-Figueras +10 more
2016OncoTarget16 citations Open access
Semantic Scholar
Vaccine Therapy in Non-Small Cell Lung Cancer
M. García-Pardo, T. Gorría, Ines Malenica, S. Corgnac +2 more
2022Vaccines14 citations Open access
Semantic Scholar
Interferon-gamma (INFG), an important marker of response to immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC) and melanoma patients.
N. Karachaliou, Guillermo Crespo, E. Aldeguer, A. Drozdowskyj +15 more
201712 citations
Semantic Scholar
RET Fusion Testing in Patients With NSCLC: The RETING Study
Esther Conde, S. Hernandez, J. L. Rodríguez Carrillo, R. Martínez +36 more
2024JTO Clinical and Research Reports11 citations Open access
Semantic Scholar
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach.
S. Hernandez, E. Conde, Aida Molero, A. Suárez-Gauthier +17 more
2023Archives of Pathology & Laboratory Medicine11 citations Open access
Semantic Scholar
Implementation of an NGS panel for clinical practice in paraffin-embedded tissue samples from locally advanced and metastatic melanoma patients
P. Castillo, M. Marginet, P. Jares, Mireia García +5 more
2020Exploration of Targeted Anti-tumor Therapy10 citations Open access
Semantic Scholar
TP53 mutation and tumoral PD-L1 expression are associated with depth of invasion in desmoplastic melanomas
L. Alós, C. Fuster, P. Castillo, P. Jares +8 more
2020Annals of Translational Medicine10 citations Open access
Semantic Scholar
Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients
E. Marin, C. Teixidó, Elena Carmona-Rocha, R. Reyes +17 more
2020Cancers9 citations Open access
Semantic Scholar
Neutrophils dominate the immune landscape of non-small cell lung cancer.
C. Teixidó, R. Rosell
2017Journal of Thoracic Disease9 citations Open access
Semantic Scholar
Targeting molecular alterations in non-small-cell lung cancer: what's next?
R. López-Castro, Tania García-Peña, X. Mielgo-Rubio, M. Riudavets +4 more
2022Personalized Medicine8 citations
Semantic Scholar
PD-L1 Expression in Non-Small Cell Lung Cancer: Data from a Referral Center in Spain
Karmele Saez de Gordoa, I. López, M. Marginet, Berta Coloma +4 more
2021Diagnostics7 citations Open access
Semantic Scholar
OA13.04 Prevalence of Molecular Alterations in NSCLC and Estimated Indoor Radon in Europe: RADON EUROPE Study
M. Garcia, M. G. de Herreros, É. Auclin, G. Caravaca +19 more
2022Journal of Thoracic Oncology6 citations Open access
Semantic Scholar
Prevalence of incidental pathogenic germline variants detected in cfDNA in patients with oncogene-driven non-small cell lung cancer.
L. Mezquita, L. Bucheit, J. Laguna, B. Pastor +15 more
2022Journal of Clinical Oncology5 citations
Semantic Scholar
Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients
E. Marin, R. Reyes, A. Arcocha, N. Viñolas +6 more
2020Diagnostics5 citations Open access
Semantic Scholar
Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion
C. Aguado, M. Gil, Z. Yeste, A. Giménez-Capitán +5 more
2018OncoTargets and Therapy5 citations Open access
Semantic Scholar
Usefulness of circulating free DNA for monitoring epidermal growth factor receptor mutations in advanced non-small cell lung cancer patients: a case report.
C. M. de las Casas, M. González-Cao, S. V. Ramírez, N. J. Ariza +7 more
2016Translational Lung Cancer Research5 citations Open access
Semantic Scholar
Using biomarkers to determine optimal combinations with immunotherapy (biomarker discovery perspective).
C. Teixidó, N. Reguart
2020Future Oncology4 citations
Semantic Scholar
EML4-ALK rearrangement in blood platelets and outcome to crizotinib in non-small-cell lung cancer patients.
N. Karachaliou, R. J. Nilsson, J. Berenguer, A. G. Capitán +16 more
20154 citations
Semantic Scholar
Immunophenotype of tumor-infiltrating lymphocytes in atypical Spitzoid tumors according to the risk of progression.
I. Moysset, Carla Fuster-Anglada, Paola Castillo, C. Teixidó +7 more
2022Annals of Diagnostic Pathology3 citations
Semantic Scholar
MA07.07 Clinical/Molecular Profile of Patients with Non-small Cell Lung Cancer (NSCLC) with Incidental Pathogenic Germline Variants Detected in cfDNA
L. Mezquita, L. Bucheit, J. C. Laguna, B. Pastor +16 more
2022Journal of Thoracic Oncology3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Rosell×20
Invite
R. Rosell — researcher profile on SciRah
N. Reguart×18
Invite
N. Reguart — researcher profile on SciRah
N. Karachaliou×15
Invite
N. Karachaliou — researcher profile on SciRah
M. Molina-Vila×13
Invite
M. Molina-Vila — researcher profile on SciRah

×11

Invite

S. Viteri — researcher profile on SciRah

Invite

R. Reyes — researcher profile on SciRah

M. González-Cao×10

Invite

M. González-Cao — researcher profile on SciRah

N. Viñolas×10

Invite

N. Viñolas — researcher profile on SciRah

A. Giménez-Capitán×9

Invite

A. Giménez-Capitán — researcher profile on SciRah

Invite

A. Prat — researcher profile on SciRah

Invite

P. Jares — researcher profile on SciRah

Invite

L. Mezquita — researcher profile on SciRah